Apollomics’ investor materials are available here.
For news updates, please sign up here.
For SEC filings, you can sign up for alerts here. Alternatively, you can view them on the SEC Filings page.
Apollomics’ fiscal year ends on December 31.
We will announce our earnings release in due course. For news updates, please sign up here.
The date and location of Apollomics’ Annual Meeting of Stockholders will be published in the company’s proxy statement, which will be announced in due course and can be found on the SEC Filings page.
You can contact IR@apollomicsinc.com for any inquiries or use our contact form here.
Apollomics common stock is traded on the Nasdaq Capital Market under the ticker APLM.
Apollomics trades on the Nasdaq Capital Market under the ticker APLM.
Apollomics began trading on the Nasdaq Capital Market on 03/30/2023 under the ticker APLM. Details of the initial public offering (IPO) are available here.
No, Apollomics does not have a direct stock purchase plan.
Apollomics has not paid any dividends to its stockholders since its inception and does not plan to pay any cash dividends in the foreseeable future.
Apollomics is located in Foster City, Calif.
989 East Hillsdale Blvd., Suite 220
Foster City, CA 94404
For any questions regarding your holdings, please contact our transfer agent, Continental Stock Transfer & Trust Company, by calling 212.509.4000 or 800.509.5586 or emailing email@example.com.
Continental Stock Transfer & Trust Company
1 State Street, 30th Floor
New York, NY 10004